Listening to music during intranasal (es)ketamine therapy in patients with treatment-resistant depression correlates with better tolerability and reduced anxiety
Frontiers in Psychiatry January 23, 2024 Johannes Hauser, Jan Sarlon, Timur Liwinski et al. 10 citations
Listening to music during intranasal (es)ketamine treatment for therapy-resistant depression is linked to reduced anxiety and lower blood pressure, stable or increased dissociation, and tolerance for higher doses. In a review of 494 sessions from 37 patients, those who listened to music received higher average doses (131.5 mg vs. 116.7 mg), reported less anxiety (0.4 vs. 1.4 points), and had lower peak systolic blood pressure (137.9 vs. 140.3 mmHg) compared to those who did not. Music did not affect depression scores between sessions.